Prime Fifty Limited
08803731
Healthy
No risk factors detected.
Details
Previously known as
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 05/12/2025
Due 19/12/2026
Industry
Officers
secretary · Since 01/01/2025
Former
director · Resigned 12/11/2020
director · Resigned 12/11/2020
director · Resigned 21/12/2022
director · Resigned 25/01/2023
director · Resigned 10/09/2025
Persons with Significant Control
Cambridge Nutraceuticals Limited
Ravenscroft House, 59-61 Regent Street, Cambridge, CB2 1AB
Reg: 07322398 · Register Of Companies For England · Private Company Limited By Shares
Notified 12/11/2020
Former PSCs
Dr Maxim Stefan Gowland
Ceased 12/11/2020
Change History
Active
Private Limited Company
SUITE 4
CAMBRIDGE
CompanyRankvs 4636+ SIC 47789 peers54
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£670k
Balance sheet strength
Cash
£683
Cash in the bank
Net Current Assets
£670k
Working capital
Current Assets
£670k
Current Liabilities
—
Debtors
£669k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | — | -£180 |
| 2023 | 46.26 | +£138k |
| 2022 | 41.50 | +£116k |
| 2021 | 42.62 | +£408k |
| 2019 | 1.02 | +£95k |
| 2018 | 16.74 | — |
Derived from filed accounts. Not audited figures.